Form 4 Filing for J. Russel Denton

J. Russel Denton, Senior Vice President, General Counsel, and Secretary of Caris Life Sciences, Inc., reported a sale of 7,500 shares of common stock on September 22, 2026. The sale was conducted at a weighted average price of $31.8168 per share, with individual transactions ranging from $31.7750 to $31.8700. Following this transaction, Mr. Denton directly owns 174,855 shares. Additionally, he indirectly owns 9,184 shares through a trust. The filing also notes shares acquired through the Caris Life Sciences, Inc. 2025 Employee Stock Purchase Plan.